Market Overview:
Pigmentation disorders like melasma, hyperpigmentation etc occur when there is an excess production of melanin pigment. Treatment options include prescription creams containing hydroquinone, retinoids, corticosteroids and other ingredients that inhibit melanin production or speed up skin cell turnover. Recently Cannabidiol (CBD) containing products have also emerged as a popular treatment choice amongst consumers for their anti-inflammatory and skin repair properties.
Market key trends:
One of the emerging trends in the pigmentation disorders treatment market is the growing popularity of cannabidiol (CBD) infused skincare products. CBD is being touted as an effective alternative to help treat various skin disorders including acne, eczema and hyperpigmentation without the side effects of prescription creams. CBD acts as an antioxidant and reduces inflammation. It also helps regulate melanin production levels in the skin. As a result, many new brands have launched CBD serums, oils and creams for pigmentation treatment in recent times to cater to the increasing demand.
Segment Analysis
The pigmentation disorders treatment market is segmented into hypopigmentation, hyperpigmentation, melasma, and vitiligo. Among these, the hyperpigmentation segment accounts for the largest share of the global market. Hyperpigmentation causes spots on the skin and skin darkening which can be disfiguring in nature. Easy availability of over-the-counter treatments and increasing awareness regarding products offering hyperpigmentation treatment are driving the growth of this segment.
Key Takeaways
The global pigmentation disorders treatment market is expected to witness high growth, exhibiting CAGR of 6.0% over the forecast period, due to increasing prevalence of pigmentation disorders and rising demand for non-invasive aesthetic treatments.
Regional analysis:
North America dominates the global pigmentation disorders treatment market, owing to rising consumer awareness about pigmentation treatment options and growing demand for non-invasive aesthetic procedures in the region. Asia Pacific is expected to grow at the fastest rate during the forecast period due to increasing disposable incomes, growing medical tourism industry and rising awareness about treatment of pigmentation disorders.
Key players:
Key players operating in the pigmentation disorders treatment market are Abbvie Inc. (Allergan Inc.), Episciences Inc., L’ORÉAL SA (SkinCeuticals International), and Pfizer Inc., among others. Abbvie Inc. (Allergan Inc.) specializes in both prescription and cosmeceutical products for pigmentation disorders treatment and accounts for the major market share.
Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
